Entrada Therapeutics (TRDA) Prepaid Assets (2020 - 2026)
Entrada Therapeutics (TRDA) recorded quarterly Prepaid Assets of $11.2 million in Q1 2026, up 28.75% quarter-over-quarter from $8.7 million in Q4 2025, and down 39.76% on a YoY basis from $18.6 million in Q1 2025.
Entrada Therapeutics (TRDA) Prepaid Assets (2020 - 2026) Analysis & Trends
Entrada Therapeutics' Prepaid Assets history runs 7 years deep, the most recent figure standing at $11.2 million for Q1 2026.
- In Q1 2026, Prepaid Assets fell 39.76% year-over-year to $11.2 million; the TTM figure through Mar 2026 stood at $11.2 million (down 39.76% YoY), while the FY2025 annual figure was $8.7 million, down 46.71% from the prior year.
- Prepaid Assets was $11.2 million for Q1 2026 at Entrada Therapeutics, up from $8.7 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $24.4 million in Q3 2023 to a low of $8.7 million in Q4 2025.
- Historically, Prepaid Assets has averaged $13.8 million across 5 years, with a median of $12.1 million in 2024.
- The sharpest annual moves came in 2022 and 2025: Prepaid Assets jumped 1316.19% in 2022, then slumped 46.71% in 2025.
- A 5-year view of Prepaid Assets shows it stood at $21.2 million in 2022, then plunged by 43.66% to $11.9 million in 2023, then jumped by 37.21% to $16.4 million in 2024, then plunged by 46.71% to $8.7 million in 2025, then rose by 28.75% to $11.2 million in 2026.
- The last three Prepaid Assets figures came in at $11.2 million (Q1 2026), $8.7 million (Q4 2025), and $10.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Entrada Therapeutics | 295.36 Mn | 295.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.23 Mn |
| Dec 31, 2025 | 8.72 Mn |
| Sep 30, 2025 | 10.22 Mn |
| Jun 30, 2025 | 13.95 Mn |
| Mar 31, 2025 | 18.63 Mn |
| Dec 31, 2024 | 16.36 Mn |
| Sep 30, 2024 | 13.39 Mn |
| Jun 30, 2024 | 12.12 Mn |
| Mar 31, 2024 | 9.24 Mn |
| Dec 31, 2023 | 11.92 Mn |
| Sep 30, 2023 | 24.44 Mn |
| Jun 30, 2023 | 9.66 Mn |
| Mar 31, 2023 | 16.21 Mn |
| Dec 31, 2022 | 21.16 Mn |
| Sep 30, 2022 | 19.16 Mn |
| Jun 30, 2022 | 9.65 Mn |
| Mar 31, 2022 | 8.81 Mn |
| Dec 31, 2021 | 7.64 Mn |
| Sep 30, 2021 | 1.35 Mn |
| Dec 31, 2020 | 904,000.00 |